A2A Pharmaceuticals Company

A2A Pharmaceuticals Inc. is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents. Their focus is on the development of novel drugs to treat antibiotic resistant bacterial infections and address unmet needs in cancer. They incorporate computational tools and interdisciplinary ingenuity into the rational design of therapeutics. Their unique computational design platform SCULPT™ integrates experimentally determined target characteristics into the systematic construction of therapeutic candidates.
Technology: Biotechnology, Health Care, Pharmaceutical, Therapeutics
Industry: Early Drug Development
Headquarters: New York, New York, United States
Founded Date: 2016-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Estimated Revenue: $1M to $10M
Last Funding Date: 2016-11-02
Last Funding Type: Convertible Note

Visit Website
Register and Claim Ownership